Hotline
organotin / related product

Moexipril hydrochloride

  Post Date: Dec 16,2021
  Expiry Date: Dec 16,2022
  Detailed Description: Cas No. :82586-52-5

Name: Moexipril hydrochloride
CAS No. : 82586-52-5
Molecular formula : C27H34N2O7.HCl
Molecular weight : 535.03
Aspect :
Melting point(℃):
Assay(%) :
Storage: Keep in well-closed
containers, in a cool and dark
place
Standard packaging:

  CAS Registry Number:

82586-52-5

  Synonyms: ;(3S-(2(R*(R*)),3R*))-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-3-isoquinolinecarboxylic acid monohydrochloride;(3S)-2-[(2S)-2-{[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino}propanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisochinolin-3-carbons?urehydrochlorid;(3S)-2-[(2S)-2-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}propanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride;(3S)-2-{N-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride;(3S)-2-{N-[(2S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]-L-alanyl}-6,7-dimethoxy-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid hydrochloride (1:1);(3S)-2-{N-[(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride (1:1);3-Isoquinolinecarboxylic acid, 2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-, (3S)-, hydrochloride (1:1);3-isoquinolinecarboxylic acid, 2-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-, (3S)-, monohydrochloride;acide (3S)-2-[(2S)-2-{[(1S)-1-(éthoxycarbonyl)-3-phénylpropyl]amino}propanoyl]-6,7-diméthoxy-1,2,3,4-tétrahydroisoquinoléine-3-carboxylique chlorhydrate;Moexipril HCl;
  Molecular Formula: C27H35ClN2O7
  Molecular Weight: 535.029
  Molecular Structure: 82586-52-5 Moexipril hydrochloride

  Hazard Symbols:  N:Dangerous for the environment;
  Risk Codes: R50:;
  Safety Description: S60:;

Tags:
Prev:
Next: